首页> 外文期刊>海南医科大学学报(英文版) >Effect of creatine phosphate sodium combined with spleen amino peptide on hand-foot-mouth disease in children with myocardial damage
【24h】

Effect of creatine phosphate sodium combined with spleen amino peptide on hand-foot-mouth disease in children with myocardial damage

机译:磷酸肌酸钠联合脾脏氨基肽对儿童心肌损伤手足口病的影响

获取原文
获取原文并翻译 | 示例
       

摘要

Objective:To explore the clinical effect of creatine phosphate sodium combined with spleen aminopeptide on treatment of hand-foot-mouth disease in children with myocardial damage. Methods:A total of 86 cases with hand-foot-mouth disease combined with cardiac damage in our hospital from January 2012 to July 2014 were randomly divided into the observation group and the control group with 43 cases in each group. Patients in the control group received conventional treatment while observation group patients were treated with creatine phosphate sodium combined with spleen amino peptide treatment. Hs-CRP, myocardial enzymes indexes, serum cytokines, NT-proBNP, PCT, endotoxin, D-lactate and immune related indicators were compared between two groups of children after treatment.Results:In observation group patients' serum IL-4, IL-6 and IL-17 levels were lower than those of of the control group after treatment (P < 0.05) while IFN-γ and IL-10 levels were higher than those of the control group (P < 0.05). In observation group patients' NT-proBNP, PCT, endotoxin and D-lactate levels were lower than those of the control group after treatment (P < 0.05). In observation group patients’ CD3+, CD4+ T lymphocytes, IgA, IgM and IgG levels were higher than those of the control group after treatment while CD8+ T lymphocyte level was lower than that of the control group (P < 0.05).Conclusions:Creatine phosphate sodium combined with spleen amino peptide treatment can effectively protect myocardial and regulate immune as well as optimize systemic inflammatory state.
机译:目的:探讨肌酸磷酸钠联合脾氨基肽治疗小儿心肌损伤手足口病的临床效果。方法:将2012年1月至2014年7月我院收治的86例手足口病合并心脏损害的患者随机分为观察组和对照组,每组43例。对照组患者接受常规治疗,观察组患者接受肌酸磷酸钠联合脾氨基肽治疗。比较两组患儿治疗后Hs-CRP,心肌酶指标,血清细胞因子,NT-proBNP,PCT,内毒素,D-乳酸及免疫相关指标。结果:观察组患者血清IL-4,IL-治疗后6和IL-17水平低于对照组(P <0.05),而IFN-γ和IL-10水平高于对照组(P <0.05)。观察组患者治疗后NT-proBNP,PCT,内毒素和D-乳酸水平均低于对照组(P <0.05)。观察组患者治疗后CD3 +,CD4 + T淋巴细胞,IgA,IgM和IgG水平高于对照组,而CD8 + T淋巴细胞水平低于对照组(P <0.05)。钠结合脾氨基肽治疗可有效保护心肌,调节免疫力,优化全身炎症状态。

著录项

  • 来源
    《海南医科大学学报(英文版)》 |2016年第11期|85-88|共4页
  • 作者单位

    Department of Internal Medicine, the First People's Hospital of Zhaoqing, Zhaoqing, Guangdong 526000, China;

    Department of Internal Medicine, the First People's Hospital of Zhaoqing, Zhaoqing, Guangdong 526000, China;

    Department of Internal Medicine, the First People's Hospital of Zhaoqing, Zhaoqing, Guangdong 526000, China;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号